Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Any info about Iomega (IOM)? -- Ignore unavailable to you. Want to Upgrade?

To: RealSmith who wrote (51512)	3/29/1998 9:43:00 AM
From: ayn rand	Respond to of 58324

Real Smith, You're exactly right. The letter indicated findings suggested zinc lozenges were ineffective. I take it you did not read the article or understand the mechanism of action for zinc lozenges. The letter you referred to was quite flawed in its analysis. They attempted to compare Zn acetate and Zn gluconate to Zn gluconate glycine, and lumped them all into one category. That makes no sense. QGLY's CE is formulated w Zn gluconate glycine and is the only clinically proven Zn formulation currently on the market that is palatable.